AstraZeneca's Oxford coronavirus vaccine is 70% efficace in media, i dati mostrano

Drugmaker AstraZeneca announced on Monday that its experimental coronavirus vaccine has shown an average efficacy of 70% nelle sue prove su larga scala — the latest of several vaccine trials worldwide to post their results this month.

The vaccine, developed with the University of Oxford, mostrato 90% efficacy in one dosing regimenwhen the vaccine was given as a half dose, followed by a full dose at least a month later — e 62% efficacy in a second regimenwhen two full doses were given at least a month apart.
That averages to a 70% efficacia, AstraZeneca said.
The company said in a news release that its vaccine washighly effective in preventing COVID-19, the primary endpoint, and no hospitalisations or severe cases of the disease were reported in participants receiving the vaccine.
    The interim analysis included a total of 131 Covid-19 cases, secondo il comunicato.
      Monday’s news comes after Moderna announced earlier this month that its vaccine was 94.5% effective against coronavirus, e Pfizer announced its vaccine was 95% efficace.
      Questa è una storia in evoluzione … more to follow

      lascia un commento

      L'indirizzo email non verrà pubblicato. i campi richiesti sono contrassegnati *